DRUG PACKAGING DEVICE
    1.
    发明申请
    DRUG PACKAGING DEVICE 审中-公开
    药物包装装置

    公开(公告)号:US20140174026A1

    公开(公告)日:2014-06-26

    申请号:US14235323

    申请日:2012-08-21

    Abstract: A packaging device eliminating waste of package paper can be provided. The packaging device includes: a computer that creates one packaging data based on prescription data regarding a plurality of patients belonging to the same group; and a packaging machine that packages a drug based on the packaging data created by the computer.

    Abstract translation: 可以提供消除包装纸浪费的包装装置。 包装装置包括:计算机,其基于关于属于同一组的多个患者的处方数据来创建一个包装数据; 以及基于由计算机创建的包装数据来包装药物的包装机。

    Method of manufacturing a semiconductor integrated circuit device and a semiconductor integrated circuit device
    6.
    发明申请
    Method of manufacturing a semiconductor integrated circuit device and a semiconductor integrated circuit device 审中-公开
    半导体集成电路器件和半导体集成电路器件的制造方法

    公开(公告)号:US20070114631A1

    公开(公告)日:2007-05-24

    申请号:US11653321

    申请日:2007-01-16

    CPC classification number: H01L21/76224 H01L27/0207 H01L27/10894

    Abstract: A method for manufacturing a semiconductor integrated circuit device includes the steps of forming an isolation trench in an isolation region of a semiconductor substrate, filling the isolation trench up to predetermined middle position in its depth direction with a first insulating film deposited by a coating method, filling a remaining depth portion of the isolation trench into which the first insulating film is filled with a second insulating film, then forming a plurality of patterns on the semiconductor substrate, filling a trench forming between the plurality of patterns up to predetermined middle position in a trench depth direction with a third insulating film deposited by a coating method, and filling a remaining portion of the trench into which the third insulating film is filled with a fourth insulating film that is more difficult to etch than the third insulating film. The method may also include the step of forming dummy patters in a relatively large isolation region of isolation regions with relatively different planar dimensions before the first insulating film is deposited.

    Abstract translation: 一种制造半导体集成电路器件的方法包括以下步骤:在半导体衬底的隔离区域中形成隔离沟槽,通过涂覆方法沉积的第一绝缘膜将隔离沟填充到其深度方向上的预定中间位置, 用第二绝缘膜填充绝缘沟槽的剩余深度部分,然后在半导体衬底上形成多个图案,在多个图案之间填充形成沟槽直到预定中间位置的沟槽 沟槽深度方向与通过涂覆方法沉积的第三绝缘膜,并且填充第三绝缘膜填充有比第三绝缘膜更难蚀刻的第四绝缘膜的沟槽的剩余部分。 该方法还可以包括在第一绝缘膜沉积之前在具有相对不同的平面尺寸的隔离区的相对大的隔离区域中形成伪图案的步骤。

    Process for manufacturing tylosin derivatives
    7.
    发明授权
    Process for manufacturing tylosin derivatives 失效
    制备泰乐菌素衍生物的方法

    公开(公告)号:US4201843A

    公开(公告)日:1980-05-06

    申请号:US881279

    申请日:1978-02-27

    CPC classification number: C07H17/08 C12P19/62 C12R1/465 C12R1/55 Y10S435/898

    Abstract: New tylosin derivatives having at least one acyl group at the 3- and 4"-positions of tylosin, and the acid addition salts thereof, which inhibit the growth of various microorganisms including drug-resistant bacterial isolants and which produce high blood levels through oral administration are produced by a biochemical reaction using the microorganisms of the genus Streptomyces which are selected for their newly-found ability to acylate at least one of the 3- and 4"-positions of macrolide antibiotics; they are recovered from the reacted mixture by conventional methods for recovering macrolide antibiotics.

    Abstract translation: 在泰乐菌素的3和4“位具有至少一个酰基的新泰乐菌素衍生物及其酸加成盐,其抑制各种微生物生长,包括耐药性细菌分离物,并通过口服产生高血药浓度 通过使用由链霉菌属(Streptomyces)属的微生物生物化学反应来产生施用,所述微生物被选择用于其新发现的能够酰化大环内酯类抗生素的3-和4-位中的至少一个的能力; 它们通过用于回收大环内酯类抗生素的常规方法从反应混合物中回收。

    Treatment of elevated histamine and uric acid levels
    8.
    发明授权
    Treatment of elevated histamine and uric acid levels 失效
    治疗组胺升高和尿酸水平升高

    公开(公告)号:US4091097A

    公开(公告)日:1978-05-23

    申请号:US769482

    申请日:1977-02-17

    CPC classification number: A61K31/235 A61K31/60

    Abstract: Compounds having the general formula ##STR1## wherein R.sup.2 is substituted either at the 4'-position or at the 5'-position and is hydrogen, fluoro, bromo, chloro, hydroxy or lower alkyl; R.sup.3 is chloro, bromo or lower alkyl; R.sup.4 is hydroxy, amino or lower alkoxy, and Z is hydrogen or lower alkyl and the nontoxic, pharmaceutically acceptable metal salts of said compounds when Z is hydrogen exhibit strong activities in inhibiting histidine decarboxylase and anthine oxidase.

    Abstract translation: 具有通式“IMAGE”的化合物,其中R 2在4位或5位被取代,为氢,氟,溴,氯,羟基或低级烷基; R3是氯,溴或低级烷基; R 4是羟基,氨基或低级烷氧基,Z是氢或低级烷基,当Z是氢时,所述化合物的无毒的药学上可接受的金属盐在抑制组氨酸脱羧酶和蒽氧化酶中表现出强烈的活性。

    Pharmaceutical method for the therapy of immune diseases
    9.
    发明授权
    Pharmaceutical method for the therapy of immune diseases 失效
    用于治疗免疫疾病的药物方法

    公开(公告)号:US4072753A

    公开(公告)日:1978-02-07

    申请号:US769481

    申请日:1977-02-17

    CPC classification number: A61K31/60

    Abstract: Compounds having the formula ##STR1## (the meanings of R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are indicated hereinafter) exhibit suppressive activity to various immune responses and can be employed in the therapy of immunological diseases, especially autoimmune diseases.One example is 3',5'-dichloro-2,4'-diacetoxybenzanilide having the formula ##STR2## and another is 3',5'-dichloro-2,4'-dibenzoyloxyanilide having the formula ##STR3##

    Abstract translation: 具有式“IMAGE”(R1,R2,R3,R4和R5的含义的化合物)在下文中表示的化合物对各种免疫反应表现出抑制活性,可用于免疫疾病,特别是自身免疫性疾病的治疗。

Patent Agency Ranking